Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Use of secondary prevention medications at the time of "MI admission" in RA and control patients with a prior history of MI

From: Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population

  RA (n= 10) Controls (n= 11)
Aspirin, n (%) 3 (30) 6 (55)
Beta blocker, n (%) 1 (10) 4 (36)
ACE inhibitor, n (%) 3 (30) 3 (27)
Lipid-lowering agent, n (%) 2 (20) 5 (45)
  1. ACE, angiotensin-converting enzyme; RA, rheumatoid arthritis.